eplerenone 50 MG Oral Tablet [Inspra]
- RxCUI
- 402105
- RxNorm name
- eplerenone 50 MG Oral Tablet [Inspra]
- Display name
- eplerenone 50 MG Oral Tablet [Inspra]
- Full name
- eplerenone 50 MG Oral Tablet [Inspra]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Inspra | EPLERENONE | Viatris Specialty LLC | 1a52bedc-8e2c-4116-a296-a87770676b4a | 2025-06-23 | Warnings, Adverse reactions | 402105 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1a52bedc-8e2c-4116-a296-a87770676b4a | INSPRA 50 MG Oral Tablet [PSN] · eplerenone 50 MG Oral Tablet [Inspra] [SBD] · Inspra 50 MG Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use INSPRA safely and effectively. See full prescribing information for INSPRA. INSPRA ® (eplerenone) tablets, for oral use Initial U.S. Approval: 2002 | 20250623 |